FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080493754> ?p ?o ?g. }

• W2080493754 endingPage "465" @default.
• W2080493754 startingPage "449" @default.
• W2080493754 abstract "We report the solid phase synthesis of four pairs of L- and D-thienylalanine (Thi/D-Thi) position two modified analogues of the following four oxytocin (OT) antagonists: des-9-glycinamide [1-(beta-mercapto-beta,beta-pentamethylene propionic acid), 2-O-methyltyrosine, 4-threonine]ornithine-vasotocin (desGly(NH2)9,d (CH2)5[Tyr(Me)2,Thr4]OVT) (A); the Tyr-(NH2)9 analogue of (A), d(CH2)5[Tyr(Me)2,Thr4,Tyr-(NH2)9]OVT (B); the Eda9 analogue (where Eda = ethylenediamine) of (A), d(CH2)5[Tyr(Me)2, Thr4, Eda9]OVT (C); and the retro Tyr10 modified analogue of (C), d(CH2)5[Tyr(Me)2, Thr4, Eda9<--Tyr10]OVT (D). The eight new analogues of A-D are (1) desGly(NH2),d(CH2)5[Thi2,Thr4]OVT, (2) desGly(NH2),d(CH2)5[D-Thi2,Thr4]OVT, (3) d(CH2)5[Thi2, Thr4,Tyr-(NH2)9]OVT, (4) d(CH2)5[D-Thi2,Thr4,Tyr-(NH2)9]OVT (5) d(CH2)5[Thi2,Thr4Eda9]OVT, (6) d(CH2)5[D-Thi2,Thr4,Eda9]OVT, (7) d(CH2) [Thi2,Thr4,Eda9<--Tyr10]OVT, (8) d(CH2),[D-Thi2,Thr4,Eda9<--Tyr10]OVT. We also report the synthesis of (C). Peptides 1-8 and C were evaluated for agonistic and antagonistic activities in in vitro and in vivo OT assays, in in vivo vasopressor (V1a receptor) assays and in in vivo antidiuretic (V2 receptor) assays. None of the eight peptides nor C exhibit oxytocic or vasopressor agonism. Peptides 1-8 are extremely weak V2 agonists (antidiuretic activities range from < 0.0005 to 0.20 U/mg). Peptide C is a weak mixed V2 agonist/antagonist. Peptides 1-8 and C exhibit potent in intro (no Mg2+) OT antagonism (anti-OT pA2 values range from 7.76 to 8.05). Peptides 1-8 are all OT antagonists in vivo (estimated in vivo anti-OT pA2 values range from 6.54-7.19). With anti-V1a pA2 values of approximately 5-5.80, peptides 1-8 exhibit marked reductions in anti-V1a potencies relative to those of the parent peptides A-D (anti-V1a pA2 range from 6.48 to 7.10) and to l-deamino[D-Tyr(Et)2, Thr4]OVT (Atosiban, trade name Tractocile) (anti-V1a pA2-6.14). Atosiban has recently been approved in Europe for clinical use for the prevention of premature labour (Pharm. J. 264(7-100): 871). Peptides 1-8 exhibit striking gains in in vitro anti-OT/anti-V1a selectivities with respect to the parent peptides A, B, C and D and to Atosiban. Peptides 1-8 exhibit anti-OT (in vitro)/anti-V1a selectivities of 450, 525, 550, 450, approximately 1080, 116, 355, 227 respectively. The corresponding values for A-D and Atosiban are 30, 4.2, 4.3, 2.6 and 37. With the exception of peptide 6, the remaining seven peptides exhibit 3-18-fold gains in anti-OT (in vivo)/anti-V1a selectivity with respect to Atosiban, peptides 1-8 exhibit anti-OT (in vivo)/anti-V1a selectivities of 22, approximately 82, approximately 82, 147, approximately 83, 11, 31 and 42. By comparison, Atosiban exhibits an anti-OT (in vivo)/anti-V1a selectivity = 8. With an estimated in vivo anti-OT pA2 value = 7.19+/-0.06, peptide 4 is equipotent with Atosiban (pA2 = 7.05+/-0.05). However, with its significantly reduced anti-vasopressor potency, pA2 = approximately 5, it is approximately 18 times more selective for OT receptors with respect to VP V1a receptors than Atosiban. Since we have shown that V1a antagonism could be an unwanted side-effect in tocolytics, peptide 4 and some of the OT antagonists reported here have advantages over Atosiban and thus may be suitable candidates for evaluation as potential tocolytic agents for the treatment of preterm labour." @default.
• W2080493754 created "2016-06-24" @default.
• W2080493754 creator A5002268768 @default.
• W2080493754 creator A5010203164 @default.
• W2080493754 creator A5045360458 @default.
• W2080493754 creator A5079582026 @default.
• W2080493754 creator A5079883467 @default.
• W2080493754 date "2001-01-01" @default.
• W2080493754 modified "2023-09-23" @default.
• W2080493754 title "Design of Oxytocin Antagonists, which are more Selective than Atosiban" @default.
• W2080493754 cites W1489889086 @default.
• W2080493754 cites W1932887617 @default.
• W2080493754 cites W1963739271 @default.
• W2080493754 cites W1965839478 @default.
• W2080493754 cites W1966163996 @default.
• W2080493754 cites W1968369855 @default.
• W2080493754 cites W1970747606 @default.
• W2080493754 cites W1973811817 @default.
• W2080493754 cites W1979636786 @default.
• W2080493754 cites W1979741250 @default.
• W2080493754 cites W1980058160 @default.
• W2080493754 cites W1980524556 @default.
• W2080493754 cites W1981274379 @default.
• W2080493754 cites W1985029759 @default.
• W2080493754 cites W1988813772 @default.
• W2080493754 cites W1989325575 @default.
• W2080493754 cites W1990738023 @default.
• W2080493754 cites W1991446640 @default.
• W2080493754 cites W1993191671 @default.
• W2080493754 cites W1994624978 @default.
• W2080493754 cites W1996957519 @default.
• W2080493754 cites W1999145058 @default.
• W2080493754 cites W1999732359 @default.
• W2080493754 cites W2000399626 @default.
• W2080493754 cites W2002444524 @default.
• W2080493754 cites W2006173028 @default.
• W2080493754 cites W2013207228 @default.
• W2080493754 cites W2016272794 @default.
• W2080493754 cites W2016676808 @default.
• W2080493754 cites W2017890520 @default.
• W2080493754 cites W2018626636 @default.
• W2080493754 cites W2019094156 @default.
• W2080493754 cites W2025314781 @default.
• W2080493754 cites W2026151231 @default.
• W2080493754 cites W2026338227 @default.
• W2080493754 cites W2027301597 @default.
• W2080493754 cites W2028082499 @default.
• W2080493754 cites W2030556522 @default.
• W2080493754 cites W2031458482 @default.
• W2080493754 cites W2032042417 @default.
• W2080493754 cites W2036763669 @default.
• W2080493754 cites W2037100519 @default.
• W2080493754 cites W2037143193 @default.
• W2080493754 cites W2040237541 @default.
• W2080493754 cites W2043556557 @default.
• W2080493754 cites W2045139592 @default.
• W2080493754 cites W2046451219 @default.
• W2080493754 cites W2048770859 @default.
• W2080493754 cites W2050575346 @default.
• W2080493754 cites W2051258740 @default.
• W2080493754 cites W2057953033 @default.
• W2080493754 cites W2058600853 @default.
• W2080493754 cites W2058808473 @default.
• W2080493754 cites W2059126503 @default.
• W2080493754 cites W2062117547 @default.
• W2080493754 cites W2062728924 @default.
• W2080493754 cites W2064501568 @default.
• W2080493754 cites W2064948049 @default.
• W2080493754 cites W2066060406 @default.
• W2080493754 cites W2069420615 @default.
• W2080493754 cites W2070821979 @default.
• W2080493754 cites W2071096462 @default.
• W2080493754 cites W2072746106 @default.
• W2080493754 cites W2075343329 @default.
• W2080493754 cites W2076576222 @default.
• W2080493754 cites W2081902301 @default.
• W2080493754 cites W2082012370 @default.
• W2080493754 cites W2082723003 @default.
• W2080493754 cites W2083099172 @default.
• W2080493754 cites W2084324077 @default.
• W2080493754 cites W2088070053 @default.
• W2080493754 cites W2088350539 @default.
• W2080493754 cites W2093269059 @default.
• W2080493754 cites W2096250412 @default.
• W2080493754 cites W2101653844 @default.
• W2080493754 cites W2111423599 @default.
• W2080493754 cites W2134389598 @default.
• W2080493754 cites W2137926707 @default.
• W2080493754 cites W2147763047 @default.
• W2080493754 cites W2161371925 @default.
• W2080493754 cites W2171098600 @default.
• W2080493754 cites W2322344246 @default.
• W2080493754 cites W2327270571 @default.
• W2080493754 cites W2328863734 @default.
• W2080493754 cites W2329971271 @default.
• W2080493754 cites W2331780577 @default.
• W2080493754 cites W2433513445 @default.
• W2080493754 cites W2949737793 @default.

• next